Exacerbation of idiopathic pulmonary fibrosis
- Authors: Avdeev S.N.1,2, Gaynitdinova V.V.1, Merzhoeva Z.M.1,2, Neklyudova G.V.1,2, Tsareva N.A.1,2, Nuralieva G.S.1,2
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Research Institute of Pulmonology
- Issue: Vol 92, No 3 (2020)
- Pages: 73-77
- Section: Consensuns
- URL: https://journals.rcsi.science/0040-3660/article/view/33906
- DOI: https://doi.org/10.26442/00403660.2020.03.000402
- ID: 33906
Cite item
Full Text
Abstract
Idiopathic pulmonary fibrosis (IPF) is usually characterized by a chronic and slowly progressive course. According to several studies, a small number of patients with IPF (about 5–15%) develops an acute deterioration of deasese – exacerbation of IPF. Exacerbations of IPF can occur at any time of the disease and sometimes becomes the first manifestation of IPF. Pulmonary hypertension in IPF is a fairly frequent complication, which leads to severe violations of gas exchange and reduced tolerance to physical stress. Currently, proven effective treatments for exacerbations of IPF do not exist, the management of this condition is based on supportive therapy (oxygen, respiratory support) and interventions with inadequate evidences (corticosteroids, immunosuppressant). During exacerbation of IPF a careful search of all the possible triggers is justified. In the presented clinical case of exacerbation of IPF there was demonstrated the efficacy of complex therapy including antifibrotic therapy, PAH-specific medicines and enhanced oxygen therapy.
Full Text
##article.viewOnOriginalSite##About the authors
S. N. Avdeev
Sechenov First Moscow State Medical University (Sechenov University); Research Institute of Pulmonology
Email: ivv_08@mail.ru
ORCID iD: 0000-0002-5999-2150
чл.-кор. РАН, д.м.н., проф., зав. каф. пульмонологии лечебного фак-та
Russian Federation, MoscowV. V. Gaynitdinova
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: ivv_08@mail.ru
ORCID iD: 0000-0001-9928-926X
д.м.н., проф. каф. пульмонологии лечебного фак-та
Russian Federation, MoscowZ. M. Merzhoeva
Sechenov First Moscow State Medical University (Sechenov University); Research Institute of Pulmonology
Email: ivv_08@mail.ru
ORCID iD: 0000-0002-3174-5000
к.м.н., ассистент каф. пульмонологии лечебного фак-та
Russian Federation, MoscowG. V. Neklyudova
Sechenov First Moscow State Medical University (Sechenov University); Research Institute of Pulmonology
Email: ivv_08@mail.ru
ORCID iD: 0000-0002-9509-0867
д.м.н., доц. каф. пульмонологии лечебного фак-та
Russian Federation, MoscowN. A. Tsareva
Sechenov First Moscow State Medical University (Sechenov University); Research Institute of Pulmonology
Email: ivv_08@mail.ru
ORCID iD: 0000-0001-9357-4924
к.м.н., доц. каф. пульмонологии лечебного фак-та
Russian Federation, MoscowG. S. Nuralieva
Sechenov First Moscow State Medical University (Sechenov University); Research Institute of Pulmonology
Email: ivv_08@mail.ru
ORCID iD: 0000-0002-4726-4906
к.м.н., доц. каф. пульмонологии лечебного фак-та
Russian Federation, MoscowReferences
- Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Диагностика и лечение идиопатического легочного фиброза. Федеральные клинические рекомендации. Пульмонология. 2016;26(4):399-419 [Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Diagnosis and treatment of idiopathic pulmonary fibrosis Federal clinical recommendations. Pulmonology. 2016; 26(4):399-419 (In Russ.)]. doi: 10.18093/0869-0189-2016-26-4-399-419
- Авдеев С.Н. Идиопатический фиброз легких: новая парадигма. Терапевтический архив. 2017;89(1):112-22 [Avdeev SN. Idiopathic pulmonary fibrosis: a new paradigm. Therapeutic Archive. 2017;89(1):112-22 (In Russ.)]. doi: 10.17116/terarkh2017891112-122
- Collard HR, Ryeson CJ, Corte TJ, et al. Acut exacerbations of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265-75. doi: 10.1055/s-0032-1325154
- Akir M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. ATR Am J Roentgenol. 1997;168:79-83. doi: 10.2214/ajr.168. 1.8976924
- Kim DS, Park JH, Lee JS, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006;27:143-50. doi: 10.1183/09031936.06.00114004
- Raghu G, Collard HR, Egan JJ and ATS/ERS/JRS/ALAT Commitee on Iidiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis; evidence-based guidelines for diagnosis and managent. Am J Respir Crit Care Med. 2011;183:788-824. doi: 10.1016/j.yrad.2012.03.015
- Collard HR, Anstrom KJ, Schwaz MI, et al. Sildenafil improveswalk distanct in idiopathic pulmonary fibrosis. Chest. 2007;131:897-9. doi: 10.1378/chest.06-2101
- Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary Hypertension in patients with idiopatic pulmonary fibrosis. Chest. 2005;128:2393-9. doi: 10.1378/chest.126.2.438
- Kimura M, Taniguchi H, Kondoh Y, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration. 2013;85:456–63. doi: 10.1159/000345221
- Lettieri CJ, Nathan SD, Barnett S, et al. Prevalence and outcomes of pulmonary arterial hypertension (PAH) in common in patients with idiopatic pulmonary fibrosis. Chest. 2006;129:746-52. doi: 10.1378/chest.129.3.746
- Nathan SD, Shlobin OA, Ahmad S, et al. Serial development pulmonary hypertension in patients with idiopatic pulmonary fibrosis. Respiration. 2008;76:288-94. doi: 10.1159/000114246
- Авдеев С.Н. Легочная гипертензия, ассоциированная с заболеваниями легких. В кн.: Легочная гипертензия. Под ред. С.Н. Авдеева. М.: Практика, 2019; с. 317-64 [Avdeev SN. Pulmonary hypertension associated with lung diseases. In: Avdeev SN, ed. Pulmonary hypertension. Moscow: Practice, 2019; p. 317-64 (In Russ.)].
- Чазова И.Е., Авдеев С.Н., Царева Н.А. и др. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтический архив. 2014;86(9):4-23 [Chazova IE, Avdeev SN, Tsareva NA, et al. Clinical practice guidelines for the diagnosis and treatment of pulmonary hypertension. Therapeutic Archive. 2014;86(9):4-23 (In Russ.)].
- Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomized controlled trial. Lancet. 2002;360:895-900. doi: 10.1016/s0140-6736(02)11024-5